The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: An open-label preliminary study
Aims: Tamsulosin, a superselective subtype alpha 1a and 1d blocker, is used for the treatment of male lower urinary tract symptoms (LUTS) commonly caused by benign prostatic hyperplasia (BPH). This prospective study evaluated the efficacy and safety of a new formulation, Tamsulosin OCAS® (Oral Contr...
Saved in:
Main Authors: | Lojanapiwat B., Permpongkosol S. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=83455172342&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43039 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: an open-label preliminary study.
by: Lojanapiwat B., et al.
Published: (2017) -
The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: An open-label preliminary study
by: Bannakij Lojanapiwat, et al.
Published: (2018) -
The effectiveness of tamsulosin in Benign Prostate Hyperplasia (BPH) patients with Lower Urinary Tract Symptoms (LUTS): a multi-centre cohort retrospective study
by: Ida Bagus Putra Pramana, et al.
Published: (2020) -
PERAN TADALAFIL DALAM MANAJEMEN LOWER URINARY TRACT SYMPTOMS AKIBAT BENIGN PROSTATIC HYPERPLASIA
by: Anugrah Dianfitriani
Published: (2016) -
Singapore urological association clinical guidelines for male lower urinary tract symptoms/benign prostatic hyperplasia
by: Foo K.T., et al.
Published: (2018)